New cancer treatment slows progression of aggressive neuroendocrine tumors, study finds

A novel approach for early cancer treatment known as radioligand therapy (RLT) has been shown to significantly reduce the risk of advanced neuroendocrine tumor progression and death, according to research led by scientists at Sunnybrook Health Sciences Centre and the University of Toronto.

This post was originally published on this site

Lawyers Lookup - LawyersLookup.ca